Full-Time

Sales Agent Ophthalmic Diagnostic

Posted on 6/5/2025

Zeiss

Zeiss

1,001-5,000 employees

Manufactures high-precision optical instruments and devices

No salary listed

Saskatchewan, Canada

In Person

Fifty percent or more of time is spent traveling; must be willing to travel in Canada and internationally for training, meetings, exhibit support and coverage outside assigned territory.

Category
Sales & Account Management (1)
Required Skills
Sales
Lead Generation
Marketing
Requirements
  • Bachelors Degree in a scientific related field (health, biology)
  • Three to five (3-5) years of sales experience
  • High level of technical/ clinical product knowledge
  • Ability to manage multiple tasks
  • Strong organizational and communication skills
  • Computer literacy in word processing, spreadsheet and database management
  • Exceptional negotiating and diplomacy skills
  • Develop expertise in product application and practice management implications
  • Safely operate a motor vehicle and maintain a valid motor vehicle license
  • Must have a valid driver’s license and good driving record
Responsibilities
  • Attain or exceed yearly revenue and profit quotas (P&L) for region of responsibility
  • Managing the entire sales process including lead generation, opportunity development, closing sales, and providing post-sale support
  • Make scheduled personalized sales demonstrations to the MD/OD market in region of responsibility
  • Complete product installation and training
  • Conducting cold calls to initiate contact with potential clients and generate new business opportunities
  • Maintains analyzes and utilizes territory records and other information to efficiently organize, plan, execute and measure results
  • Educate and follow up the Ophthalmologists, Optometrists and staff members on the operation, utilization and application of our product to ensure overall customer satisfaction
  • Provide timely, accurate and constructive written and oral communications to management regarding expected sales and planned monthly activity
  • Be responsible and assist in market introductions and launches of new products planning
  • Develop and implement synergy opportunities among other Zeiss team members, companies, Carl Zeiss field service and other corporate partners when such programs arise
  • All paperwork and other requested information should be furnished in a complete and timely manner
  • Assist / advise the local sales administration personnel, when necessary, on all matters pertaining to processing of customer orders, deliveries, etc.
  • A good working relationship with colleagues, service and office personnel is vital
  • Maintain currency of and adhere to applicable Company and ISO 9001 processes and procedures
  • Develop and implement creative and profitable marketing approaches to the individual demands of the region
  • Abide by provincial and federal employment laws
Desired Qualifications
  • Experience working in Ophthalmology / Optometry is an asset
  • The ideal candidate will be proactive, results-driven with a hunter mindset
  • Fifty percent or more of time is spent traveling
  • Ability to travel to the U.S.A. for training
  • Extensive travel is required by automobile and/or air. Must be willing to travel in Canada and internationally for training, meetings, exhibit support and coverage outside assigned territory
  • The demonstration of product can require weekend work and frequent traveling

ZEISS is a global leader in optics and optoelectronics, serving medical professionals, industrial manufacturers, consumers, and the semiconductor industry. It designs and sells high-precision optical instruments, medical devices, semiconductor manufacturing equipment, and vision care products such as corrective lenses and eye-health services. Its products rely on advanced optics and imaging technologies to deliver accurate inspection, diagnosis, and manufacturing outcomes across healthcare, industrial quality control, consumer optics, and chip fabrication. What sets ZEISS apart is its breadth and depth: a long-standing scale in multiple markets, integrated solutions across optics, imaging, metrology, and precision engineering, and a commitment to sustainability in electricity use and carbon emissions. The company’s goal is to advance optics and optoelectronics by providing reliable, high-quality tools and services worldwide while operating in a sustainable way.

Company Size

1,001-5,000

Company Stage

Growth Equity (Non-Venture Capital)

Total Funding

$1.1B

Headquarters

Oberkochen, Germany

Founded

2001

Simplify Jobs

Simplify's Take

What believers are saying

  • Shop-floor metrology adoption accelerates CMM sales into automotive, aerospace, heavy equipment sectors.
  • Cloud-based Collaborative Care extends subscription licensing model to industrial quality networks.
  • MICOR 700 ultrasound-free handheld device opens portable metrology market in surgical applications.

What critics are saying

  • ASML's EUV lithography monopoly threatens ZEISS semiconductor optics segment revenue sustainability.
  • VisioGen AI platform faces FDA liability exposure if AI responses cause patient harm.
  • Ransomware attack on ZEISS Health Data Platform halts clinical workflows across customer sites.

What makes Zeiss unique

  • ZEISS dominates precision optics across semiconductor, medical, and industrial segments globally.
  • ARTEVO 850 microscope offers 60% depth-of-field increase with true 3D visualization capability.
  • VisioGen AI platform provides human-verified patient engagement integrated into ophthalmology workflows.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Zeiss who can refer or advise you

Benefits

Health Insurance

401(k) Retirement Plan

Paid Vacation

Performance Bonus

Growth & Insights and Company News

Headcount

6 month growth

-2%

1 year growth

-2%

2 year growth

-2%
PR Newswire
Apr 2nd, 2026
ZEISS unveils AI-powered patient platform and enhanced IOL tools at ASCRS

ZEISS has unveiled new digital, AI and surgical innovations for cataract and refractive workflows at the ASCRS conference. The medical technology company is expanding its US cataract portfolio with new irrigation/aspiration handpieces compatible with the DORC EVA NEXUS surgical system, alongside enhanced IOL calculation capabilities for the ZEISS IOLMaster 700. ZEISS also launched VisioGen commercially in the US, a human-verified AI patient engagement platform for ophthalmology practices. The platform integrates with clinic websites to capture patient demand around the clock, with AI-assisted responses reviewed by ZEISS-trained optometrists before delivery. The company showcased ZEISS Collaborative Care, a cloud-based application enabling secure data sharing between eye care professionals, and previewed ZEISS CLINIC 360, pending FDA clearance. ZEISS is celebrating 100 years of US operations this year.

PR Newswire
Mar 24th, 2026
ZEISS expands ophthalmic portfolio in Canada with new diagnostic lasers and workflow tools

ZEISS Medical Technology has expanded its ophthalmic workflow portfolio in Canada with new diagnostic, visualisation and therapeutic solutions. The company will showcase the innovations at upcoming Canadian ophthalmology conferences in Ottawa and Montréal. Key additions include ICGA for ZEISS CLARUS 700, offering simultaneous FA and ICG capture for clinical assessment, and ZEISS VISULAS green with selective laser trabeculoplasty for retinal photocoagulation. The company has introduced refraction devices ZEISS VISUREF 600 and ZEISS VISUCORE 500 to streamline diagnostic workflows. ZEISS also launched VISULAS yag, a new-generation therapeutic laser for anterior segment photodisruption within cataract workflows. The ZEISS FORUM subscription package, now available in Canada, offers integrated data management with unlimited device licences and lower upfront costs.

PR Newswire
Feb 23rd, 2026
ZEISS launches Collaborative Care app for eye care professionals with cloud and on-premises options

ZEISS Medical Technology has launched Collaborative Care, a browser-based application enabling eye care professionals to share data securely, refer patients and coordinate clinical care. Built on the ZEISS Health Data Platform, the solution addresses fragmented data sharing and inefficient referral processes in ophthalmic care. The application offers flexible deployment as either a standalone cloud solution or an integrated extension of ZEISS FORUM. Key features include secure exchange of images and reports, streamlined referral workflows with tracking capabilities, and tools for building professional networks between optometrists and ophthalmologists. ZEISS Collaborative Care was demonstrated at industry events in London and Orlando in February and March 2026. The company generated €2,228 million in revenue in fiscal year 2024/25 with 5,784 employees worldwide.

Handelsblatt
Feb 19th, 2026
Custom Surgical raises $4M to develop AI-powered ophthalmology platform

Custom Surgical, a German ophthalmology company, has raised €3.5 million to advance its platform. The funding will support development of AI-powered features including automated image optimisation and assisted triage processes that help determine case urgency and specialist assignment. The company is already developing its first AI-based triage and screening system. The technology aims to provide initial assessments that guide decisions on how urgently cases need attention and which medical professionals should handle them next.

Investors Hangout
Feb 18th, 2026
Mindpeak raises $15.3M Series A to scale AI cancer diagnostic tools

Mindpeak, an AI-driven pathology startup, raised $15.3 million in a Series A round led by ZEISS Ventures and InnoVentureFund in 2024. The funding will accelerate development and deployment of the company's AI diagnostic tools for cancer pathology. Founded in 2018, Mindpeak's algorithms have supported over 30,000 patient diagnoses across US and European healthcare markets. The technology uses automated histological analyses to help pathologists make faster, more precise clinical decisions. CEO Felix Faber stated the capital would expedite product rollouts and expand capabilities. The company has established strategic partnerships with major players including Roche. Mindpeak operates in the rapidly growing digital pathology market, driven by technological innovation and increasing demand for advanced diagnostic services in an ageing population.

INACTIVE